Clinical trials recruiting in Lebanon

Phase breakdown

Cities in Lebanon

Conditions recruiting in Lebanon

Recruiting trials in Lebanon

• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
  NCT06609226 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female)
• A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
  NCT05970172 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female)
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease
  NCT06198712 · Phase: Phase 2 · Ages: 6 Months to 18 Years · Sex: All (male and female)
• AI Avatar Video vs. Tell-Show-Do for Reducing Anxiety and Improving Cooperation in Children During Local Anesthesia
  NCT07449884 · Phase: Not applicable (e.g. observational or device study) · Ages: 5 Years to 7 Years · Sex: All (male and female)
• Impact of Intermittent Fasting on the Mental Health of Perimenopausal Women
  NCT07481513 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 55 Years · Sex: Female
• Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
  NCT05682378 · Phase: Phase 3 · Ages: 12 Years to 100 Years · Sex: All (male and female)
• PLADO for Conservative Management of CKD
  NCT06932042 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA
  NCT06307249 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female)
• Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
  NCT04657822 · Phase: Phase 4 · Ages: 6 Months to 100 Years · Sex: All (male and female)
• Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
  NCT04580420 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female)
• The Effect of Different Diets on Arterial Stiffness in Obese Patients on Semaglutide
  NCT04990024 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 49 Years · Sex: All (male and female)
• The Effect of Oral Iron Supplements on Insulin and Glucose Metabolism in Overweight and Obese Women
  NCT07315282 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: Female
• Vitamin K2 Supplementation in Adult Episodic Migraine
  NCT05943457 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Lebanon?

14 recruiting trials have at least one study site in Lebanon.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.